is zepbound a glp 1 agonist Effective for Weight Loss for People with Multiple Conditions What is ZepboundⓇ? - GLP-1
Description
In a study of 3,731 patients assigned to take either liraglutide or placebo, 63.2% of patients taking liraglutide lost at least 5% of their body weight and 33.1% of patients lost at least 10% of their body weight
Then some charge a monthly fee for follow-ups, as well as a monthly cost for the prescription
It is prescribed to patients with diabetes
semaglutide GLP-1
Blood sugar control appears slightly better with tirzepatide in head-to-head trials, possibly due to GIPs robust insulin secretion effects
